Redsense Medical AB

REDS · Nasdaq Stockholm · Healthcare

3.69SEK +7.6%last day

Price as of 1 October 2026

The price over the past year, with dividends: −25.9%

Performance

1 month

+19.4%

1 year

−25.9%

3 years, per year

−27.2%

5 years, per year

−33.3%

Largest fall, 3 years

−89.4%

Below the peak now

−93.1%

Volatility, 1 year

79.0%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

1.6

Dividend yield

0.0%

Return on equity

−1.8%

Net margin

−2.5%

Market value

6 m USD

Quality, value and trend

Where Redsense Medical stands against every Nordic stock today. 100 is best.

Quality37

Profitability and a sound balance sheet over time. Better than 37% of Nordic stocks.

Value40

The price measured against earnings, assets and cash flow. Better than 40% of Nordic stocks.

Trend36

The price development over the past year. Better than 36% of Nordic stocks.

Combined25

Quality, value and trend together. Better than 25% of Nordic stocks.

About Redsense Medical

Redsense Medical AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 4 employees.

Redsense Medical AB (publ) provides an alarm in the event of blood leakage to monitor hemodialysis treatments in Europe, Canada, and Australia. It offers alarm units, such as Redsense, an alarm system for monitoring the blood access during hemodialysis; sensor patches to monitor venous needle or catheter access; and Redsense clamps to automatically stop the blood flow. The company was founded in 2000 and is headquartered in Halmstad, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis